File size: 6,924 Bytes
0240893 815e563 25044b7 35a97c5 35d6ad3 35a97c5 0240893 35d6ad3 35a97c5 0240893 35d6ad3 0240893 35a97c5 0240893 35a97c5 12ae02c 35a97c5 12ae02c 35a97c5 12ae02c 35a97c5 12ae02c 35a97c5 12ae02c 35a97c5 12ae02c 35d6ad3 35a97c5 35d6ad3 35a97c5 12ae02c 35a97c5 9c4836d 35a97c5 12ae02c 35a97c5 9c4836d 35a97c5 35d6ad3 12ae02c 35a97c5 12ae02c 35a97c5 dfdecdb 12ae02c dfdecdb 35d6ad3 |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 |
---
base_model: meta-llama/Llama-3.1-8B-Instruct
datasets:
- Moreza009/drug_approval_prediction
library_name: peft
license: apache-2.0
pipeline_tag: text-generation
tags:
- medical
- biology
- chemistry
---
[](https://arxiv.org/abs/2508.18579)
[](https://github.com/mohammad-gh009/DrugReasoner)
# DrugReasoner: Interpretable Drug Approval Prediction with a Reasoning-augmented Language Model
DrugReasoner is an AI-powered system for predicting drug approval outcomes using reasoning-augmented Large Language Models (LLMs) and molecular feature analysis. By combining advanced machine learning with interpretable reasoning, DrugReasoner provides transparent predictions that can accelerate pharmaceutical research and development.
## Abstract
Drug discovery is a complex and resource-intensive process, making early prediction of approval outcomes critical for optimizing research investments. While classical machine learning and deep learning methods have shown promise in drug approval prediction, their limited interpretability constraints their impact. Here, we present DrugReasoner, a reasoning-based large language model (LLM) built on the LLaMA architecture and fine-tuned with group relative policy optimization (GRPO) to predict the likelihood of small-molecule approval. DrugReasoner integrates molecular descriptors with comparative reasoning against structurally similar approved and unapproved compounds, generating predictions alongside step-by-step rationales and confidence scores. DrugReasoner achieved robust performance with an AUC of 0.732 and an F1 score of 0.729 on the validation set and 0.725 and 0.718 on the test set, respectively. These results outperformed conventional baselines, including logistic regression, support vector machine, and k-nearest neighbors and had competitive performance relative to XGBoost. On an external independent dataset, DrugReasoner outperformed both baseline and the recently developed ChemAP model, achieving an AUC of 0.728 and an F1-score of 0.774, while maintaining high precision and balanced sensitivity, demonstrating robustness in real-world scenarios. These findings demonstrate that DrugReasoner not only delivers competitive predictive accuracy but also enhances transparency through its reasoning outputs, thereby addressing a key bottleneck in AI-assisted drug discovery. This study highlights the potential of reasoning-augmented LLMs as interpretable and effective tools for pharmaceutical decision-making.
## β¨ Key Features
- **π€ LLM-Powered Predictions**: Utilizes fine-tuned Llama model for drug approval prediction
- **𧬠Molecular Analysis**: Advanced SMILES-based molecular structure analysis
- **π Interpretable Results**: Clear reasoning behind predictions for better decision-making
- **π Similarity Analysis**: Identifies similar approved/non-approved compounds for context
- **β‘ Flexible Inference**: Support for both single molecule and batch predictions
## Model Details
- Model Name: DrugReasoner
- Training Paradigm: Group Relative Policy Optimization (GRPO)
- Input: SMILES Structure
- Output: Drug approval prediction + Rational of approval or unapproval + Confidence score
- Training Libraries: Hugging Faceβs transformers, Transformer Reinforcement Learning (TRL), and Parameter-efficient fine-tuning (PEFT)
- Model Sources: meta-llama/Llama-3.1-8B-Instruct
## How to Get Started with the Model
- To use **DrugReasoner**, you must first request access to the base model [Llama-3.1-8B-Instruct](https://huggingface.co/meta-llama/Llama-3.1-8B-Instruct) on Hugging Face by providing your contact information. Once access is granted, you can run DrugReasoner either through the command-line interface (CLI) or integrate it directly into your Python workflows.
### Prerequisites
- Python 3.8 or higher
- CUDA-compatible GPU (recommended for training and inference)
- Git
### Setup Instructions
1. **Clone the repository**
```bash
git clone https://github.com/mohammad-gh009/DrugReasoner.git
cd DrugReasoner
```
2. **Create and activate virtual environment**
**Windows:**
```bash
cd src
python -m venv myenv
myenv\Scripts\activate
```
**Mac/Linux:**
```bash
cd src
python -m venv myenv
source myenv/bin/activate
```
3. **Install dependencies**
```bash
pip install -r requirements.txt
```
4. **Login to your Huggingface account**
You can use [this](https://huggingface.co/join) instruction on how to make an account and [this](https://huggingface.co/docs/hub/en/security-tokens) on how to get the token
```bash
huggingface-cli login --token YOUR_TOKEN_HERE
```
## π How to use
**Note:** GPU is required for inference. If unavailable, use our [Kaggle Notebook](https://www.kaggle.com/code/mohammadgh009/drugreasoner).
#### CLI Inference
```bash
python inference.py \
--smiles "CC(C)CC1=CC=C(C=C1)C(C)C(=O)O" "CC1=CC=C(C=C1)C(=O)O" \
--output results.csv \
--top-k 9 \
--top-p 0.9 \
--max-length 4096 \
--temperature 1.0
```
#### Python API Usage
```python
from inference import DrugReasoner
predictor = DrugReasoner()
results = predictor.predict_molecules(
smiles_list=["CC(C)CC1=CC=C(C=C1)C(C)C(=O)O"],
save_path="results.csv",
print_results=True,
top_k=9,
top_p=0.9,
max_length=4096,
temperature=1.0
)
```
## π Dataset & Model
- **Dataset**: [](https://huggingface.co/datasets/Moreza009/drug_approval_prediction)
- **Model**: [](https://huggingface.co/Moreza009/Llama-DrugReasoner)
## π Performance
DrugReasoner demonstrates superior performance compared to traditional baseline models across multiple evaluation metrics. Detailed performance comparisons are available in our [paper](https://arxiv.org/abs/2508.18579).
## Citation
If you use DrugReasoner in your research, please cite our work:
```
@misc{ghaffarzadehesfahani2025drugreasonerinterpretabledrugapproval,
title={DrugReasoner: Interpretable Drug Approval Prediction with a Reasoning-augmented Language Model},
author={Mohammadreza Ghaffarzadeh-Esfahani and Ali Motahharynia* and Nahid Yousefian and Navid Mazrouei and Jafar Ghaisari and Yousof Gheisari},
year={2025},
eprint={2508.18579},
archivePrefix={arXiv},
primaryClass={cs.LG},
url={https://arxiv.org/abs/2508.18579},
}
```
## π License
This project is licensed under the Apache License 2.0 - see the [LICENSE](LICENSE) file for details.
---
<div align="center">
<strong>Accelerating drug discovery through AI-powered predictions</strong>
<br><br>
</div> |